Page last updated: 2024-11-03

probenecid and Enterobacteriaceae Infections

probenecid has been researched along with Enterobacteriaceae Infections in 3 studies

Probenecid: The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy.
probenecid : A sulfonamide in which the nitrogen of 4-sulfamoylbenzoic acid is substituted with two propyl groups.

Enterobacteriaceae Infections: Infections with bacteria of the family ENTEROBACTERIACEAE.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Grajwer, LA1
Mukhopadhyay, D1
Grossman, BJ1
Miller, AK1
Celozzi, E1
Kong, Y1
Pelak, BA1
Hendlin, D1
Stapley, EO1
Bodey, GP1
Rodriguez, V1
Luce, JK1

Other Studies

3 other studies available for probenecid and Enterobacteriaceae Infections

ArticleYear
Chronic polymicrobial bacteremia.
    Clinical pediatrics, 1975, Volume: 14, Issue:3

    Topics: Adolescent; Ampicillin; Blood Bactericidal Activity; Carbenicillin; Chronic Disease; Enterobacteriac

1975
Cefoxitin, a semisynthetic cephamycin antibiotic: in vivo evaluation.
    Antimicrobial agents and chemotherapy, 1974, Volume: 5, Issue:1

    Topics: Animals; Biological Assay; Carbamates; Cephalosporins; Drug Evaluation; Enterobacteriaceae Infection

1974
Carbenicillin therapy of gram-negative bacilli infections.
    The American journal of the medical sciences, 1969, Volume: 257, Issue:6

    Topics: Adolescent; Cellulitis; Child; Enterobacteriaceae Infections; Escherichia coli Infections; Humans; K

1969